Skip to content
Bilcare logo

Bilcare

BI NSE
₹82.79 up 1.35 (1.66%)
Market Cap
₹195 Cr

Bilcare (BI) share price was ₹81.44 at the 28 Oct 2026 close; market capitalisation ₹192 Cr; sector Healthcare. The share price fell 22.6% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 21.2% year on year to ₹225.9 Cr and net profit was ₹15 Cr, against −₹10 Cr a year earlier (compared with Jun 2025). Promoters held 30.01% of Bilcare in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 50/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹81.44 −21.81 −21.12% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹195 Cr
EBITDA
₹74.40 Cr
Return on Equity
-23.31%
Debt to Equity
3.15
Book Value
₹83.55
EPS (TTM)
—
52W High
₹113.00
52W Low
₹50.00

Price-based figures as of 29 Oct 2026, 10:48 IST · TTM

Peer Comparison

Healthcare › Healthcare Technology › Healthcare Research, Analytics & Technology

Syngene International
₹407.3074.1916,441 Cr3.380.34%6.54%8.35%3,613 Cr221 Cr
Indegene
₹597.3535.8614,394 Cr4.590.38%12.78%15.40%3,892 Cr401 Cr
Suven Life Sciences
₹264.65—7,478 Cr10.920.00%-46.73%-45.62%30 Cr-353 Cr
Vimta Labs
₹514.8028.842,301 Cr5.040.39%12.83%16.36%336 Cr80 Cr
Fabtech Technologies
₹119.929.01533 Cr1.270.47%9.14%11.73%441 Cr49 Cr
Bilcare (this company)
₹82.79—195 Cr0.990.00%-23.31%9.24%799 Cr-6 Cr
Take
₹10.7012.30158 Cr5.100.00%13.73%15.37%100 Cr13 Cr
Median 7 companies₹264.6528.842,301 Cr4.590.34%9.14%11.73%441 Cr49 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

50 Average
Overall score

Data confidence 98/100

surveillance:ESM1

Category scores

Quality Average 50
Returns, margins, earnings quality 22% weight
Valuation Strong 74
Cheap vs sector & own history 24% weight
Growth Poor 36
Sales & profit trajectory 9% weight
Financial Health Poor 21
Solvency, leverage, coverage 9% weight
Momentum Strong 89
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 1.13 times its book value

Weaknesses

5
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 3.33% over past five years.
  • Promoter holding is low: 30.0%
  • Company has a low return on equity of -2.83% over last 3 years.
  • Contingent liabilities of Rs.725 Cr.

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bearish

Bearish
9
Neutral
4
Bullish
6

Moving Averages

Bearish

Bearish
7
Neutral
0
Bullish
3

Growth Rate

Revenue Growth
-5.33% higher than 3Y

change over 1 year

Net Income Growth
-38.65% lower than 3Y

change over 1 year

Cash Flow Change
47.91%

change over 1 year

EBITDA Margin Change
22.8%

change over 1 year Operating margin 16% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
182
190
175
200
194
202
198
194
186
178
181
188
226
Expenses
169
173
158
208
175
194
187
186
175
175
168
171
189
Operating Profit
13
17
17
-8
19
8
11
8
11
3
13
17
37
OPM %
7%
9%
10%
-4.1%
10%
3.8%
5%
4%
6%
1.9%
7%
9%
16%
Other Income
3
1
4
9
4
-6
-6
21
6
4
3
12
0
Interest
19
20
21
23
21
24
19
19
19
19
17
18
18
Depreciation
10
10
11
13
12
11
12
5
12
12
5
5
4
PBT
-13
-13
-10
-35
-10
-33
-27
6
-13
-24
-6
7
15
Tax %
-1%
-5%
34%
-44%
55%
-10%
-40%
-119%
-25%
-1%
3%
-13%
-1%
Net Profit
-13
-12
-14
-20
-15
-30
-16
12
-10
-23
-6
8
15
EPS (₹)
-3.36
-3.22
-2.91
-4.63
-2.71
-6.81
-3.04
7.47
-1.61
-5.25
0.41
5.68
5.39
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
2,692
2,603
2,633
2,778
2,997
1,827
623
845
982
747
788
734
773
Expenses
2,506
2,396
2,443
2,617
2,827
1,782
572
784
925
708
742
689
703
Operating Profit
186
207
190
161
170
45
51
60
57
39
46
45
70
OPM %
7%
8%
7%
6%
6%
2.5%
8%
7%
6%
5%
6%
6%
9%
Other Income
9
-87
107
297
59
254
45
44
237
16
12
26
20
Interest
236
151
176
249
283
174
76
69
60
82
83
72
72
Depreciation
191
164
177
416
378
239
46
39
38
45
18
20
26
PBT
-232
-194
-56
-207
-433
-114
-25
-4
196
-72
-43
-21
-7
Tax %
-7%
-58%
42%
-4%
5%
-13%
-55%
3%
74%
-18%
-35%
-19%
—
Net Profit
-216
-82
-80
-199
-453
-99
-11
-4
50
-59
-28
-17
-6
EPS (₹)
-91.76
-36.04
-35.91
-85.43
-193
-43.97
-8.95
-5.35
6.39
-14.12
-0.33
0.73
6.23
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
24
24
24
24
24
24
24
24
24
24
24
24
Reserves
1,073
689
590
376
-93
85
63
52
507
474
191
173
Borrowings
2,311
2,122
2,014
2,089
2,270
707
677
690
639
756
689
620
Other Liabilities
933
786
830
913
888
297
300
362
424
314
21
26
Total Liabilities
4,340
3,620
3,457
3,402
3,087
1,112
1,064
1,127
1,593
1,568
924
843
Fixed Assets
1,926
2,432
2,403
2,180
2,005
534
494
465
1,045
1,038
456
432
CWIP
218
161
149
170
79
0
0
1
1
1
4
10
Investments
0
1
0
1
0
0
0
0
2
8
11
14
Other Assets
2,196
1,026
904
1,051
1,003
577
570
661
545
521
453
387
Total Assets
4,340
3,620
3,457
3,402
3,087
1,112
1,064
1,127
1,593
1,568
924
843
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-315
177
300
98
206
256
72
41
-7
62
86
128
Investing
247
-358
-129
-203
-104
1,309
2
-4
36
-106
81
-5
Financing
119
149
-155
91
-103
-1,600
-83
-55
-19
36
-171
-132
Net Cash Flow
50
-32
16
-13
-1
-35
-9
-18
10
-7
-3
-10
Free Cash Flow
-74
-12
165
-115
91
1,569
69
37
11
-34
142
120
CFO/OP
-170
85
173
75
148
828
141
78
-6
162
192
283
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
125
35
29
38
38
22
90
95
70
73
55
54
Inventory Days
105
108
84
90
82
28
90
83
42
77
80
86
Days Payable
93
86
81
102
71
35
93
102
77
70
57
70
Cash Conversion Cycle
137
57
32
25
49
15
88
76
34
80
78
69
Working Capital Days
125
5
-11
-150
-156
-2
-19
-10
-10
12
-5
28
ROCE %
1%
2%
2%
-8%
-6%
-9%
3%
3%
3%
1%
4%
7%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Bilcare insights

63 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

FIIs0.04%Public45.33%Others24.61%Promot.30.01%As ofSep 2026
1.39% of promoter holding pledged as of 14 Oct 2026

Documents

Frequently Asked Questions about Bilcare

What does Bilcare Ltd do?
Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).
Where is Bilcare Ltd (BI) listed?
Bilcare Ltd trades as BI on the NSE and under code 526853 on the BSE.
Which sector does Bilcare Ltd belong to?
Bilcare Ltd is classified under the Healthcare sector, in the Healthcare Technology industry.
What is the market capitalisation of Bilcare Ltd?
Bilcare Ltd has a market capitalisation of ₹194.93 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Bilcare Ltd?
Over the last 52 weeks Bilcare Ltd has traded between ₹50 and ₹113 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Bilcare Ltd?
Bilcare Ltd reported a return on equity of -23.31%. Its debt-to-equity ratio is 3.15.

Company Information

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

Website bilcare-group.com
Listed 2026-04-20
Face Value ₹ 10
Shares Outstanding 2,35,45,231

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526853.md for Bilcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month